Milad Mashinchian

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Tabriz University of Medical Sciences(Current)

Milad Mashinchian is an author at Tabriz University of Medical Sciences specializing in triple-negative breast cancer therapy, chemotherapy, and cell-nanoparticle interactions.

Publications per year

2024–2024

Publications

Chitosan nanoparticles loaded with metformin and digoxin synergistically inhibit MCF-7 breast cancer cells through suppression of NOTCH-1 and HIF-1α gene expression

Hamed Dadashi, Milad Mashinchian, Alireza Karimian-Shaddel et al. · International Journal of Biological Macromolecules · 2024 · 19 citations

Pharmacy, Oncology, Pharmacology +16

Codelivery of metformin and methotrexate with optimized chitosan nanoparticles for synergistic triple-negative breast cancer therapy in vivo

Alireza Karimian-Shaddel, Hamed Dadashi, Milad Mashinchian et al. · International Journal of Pharmaceutics · 2024 · 17 citations

Pharmacy, Oncology, Pharmacology +14

1–2 of 2